Sarepta Therapeutics reported $2.66B in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Avrobio Inc AVRO:US $ 175.34M 28.49M
Capricor Therapeutics CAPR:US $ 64.92M 23.59M
Newlink Genetics NLNK:US $ 93.19M 7.12M